Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEX-IN for pain in outpatient procedures
NCT03348423Phase 2Completed
- Sponsor
- Baudax Bio
- Start
- Nov 2017
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dexmedetomidine in pain, sponsored by Baudax Bio. Started Nov 2017; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
pain
Beyond the preview
Go deeper on NCT03348423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03348423.